| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 03/21/2002 | WO2001060991A3 Human kinases |
| 03/21/2002 | WO2001059154A3 Process for characterising nucleic acids in solution |
| 03/21/2002 | WO2001058954A3 Trade molecules and uses related thereto |
| 03/21/2002 | WO2001058914A3 Haplotypes of the interleukin 15 gene |
| 03/21/2002 | WO2001051638A3 Drug metabolizing enzymes |
| 03/21/2002 | WO2001042500A3 Testing xenografts and sources thereof for retrovirus |
| 03/21/2002 | WO2001040465A3 Compositions and methods for the treatment of immune related diseases |
| 03/21/2002 | WO2001038567A3 Genetic indicators of tobacco consumption |
| 03/21/2002 | WO2001037779A3 A novel method of diagnosing, monitoring, staging, imaging and treating breast cancer |
| 03/21/2002 | WO2001037191A3 Method for manipulating protein or dna sequence data (in order to generate complementary peptide ligands) |
| 03/21/2002 | WO2001034842A3 Pcr amplification on microarrays of gel immobilized oligonucleotides |
| 03/21/2002 | WO2001034831A3 Determination of catalase activity |
| 03/21/2002 | WO2001020039A3 Method of sequencing a nucleic acid |
| 03/21/2002 | WO2001012855A3 Binary encoded sequence tags |
| 03/21/2002 | WO2001010199A9 A knockout mouse for the tumor suppressor gene anx7 |
| 03/21/2002 | WO2000068424A3 Means for detecting and treating pathologies linked to fgfr3 |
| 03/21/2002 | WO2000063444A3 Method for detecting hepatitis c virus with hybridomas |
| 03/21/2002 | WO2000052208A3 Customized oligonucleotide microchips that convert multiple genetic information to simple patterns |
| 03/21/2002 | US20020035742 Powdery mildew resistant plants |
| 03/21/2002 | US20020035735 Reproducing and animal; obtain preferential embryonic cells, culture cells, transfer cells to primate, recover infant |
| 03/21/2002 | US20020035734 Binding protein for use in the treatment of neutropenia, infections and cancer |
| 03/21/2002 | US20020035459 Pharmacokinetic-based drug design tool and method |
| 03/21/2002 | US20020035246 SMAD-interacting polypeptides and their use |
| 03/21/2002 | US20020035244 Reagents and methods useful for detecting diseases of the prostate |
| 03/21/2002 | US20020035084 Protecting the agent (such as chemotherapeutic agent) within a lipid structure, causing lipase activity to be constituted in response to predetermined conditions, and exposing the lipid structure to release the agent |
| 03/21/2002 | US20020035078 Enzyme having S-adenosyl-L-homocysteine hydrolase (AHCY) type activity |
| 03/21/2002 | US20020035061 Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics |
| 03/21/2002 | US20020035060 Pharmaceutical compositions, methods, and kits for treatment and diagnosis of lung cancer |
| 03/21/2002 | US20020035058 Isopentenyl pyrophosphate isomerase (IPI) and/or prenyl transferase inhibitors |
| 03/21/2002 | US20020034820 Sebocytes, sebocyte-cell line and uses thereof |
| 03/21/2002 | US20020034812 Caspase homologue |
| 03/21/2002 | US20020034808 Crystal of bacterial core RNA polymerase |
| 03/21/2002 | US20020034806 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses thereof |
| 03/21/2002 | US20020034803 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 03/21/2002 | US20020034800 Preferential bone marrow polypeptides; for generation of erythrocytes; for healing fractured bones |
| 03/21/2002 | US20020034792 Reduced ability to incorporate dideoxynucleotides |
| 03/21/2002 | US20020034791 Method for producing DNA |
| 03/21/2002 | US20020034790 Calibration of nucleotide sequences; generate preferential nucleotide sequences, incubate with hapten, remove and evaluate hybridized nucleotide sequences |
| 03/21/2002 | US20020034787 Nucleotide sequences coding polypeptides for use in treatment of wounds, burns, ulcers, nervous system disorders and tumors |
| 03/21/2002 | US20020034786 Nucleotide sequences coding G protein coupled receptor; for use in the diagnosis and treatment of defects in signal transduction |
| 03/21/2002 | US20020034779 Novel argS |
| 03/21/2002 | US20020034778 Peptide; for use in drug screening; for use as a diagnostic tool; for use in the treatment of nervous system disorders |
| 03/21/2002 | US20020034777 Modulator of use in the diagnosis, prevention and treatment of inflammation, cancer and nervous system disorders; hypotensive agent |
| 03/21/2002 | US20020034775 Diagnosis of preferential enzymatic defect in humans; obtain sample of body fluid, monitor enzymatic activity, compare to control, adjustment in enzyme activity indicates defect |
| 03/21/2002 | US20020034772 Methods and compositions that affect melanogenesis |
| 03/21/2002 | US20020034766 Molecular modification assays |
| 03/21/2002 | US20020034762 Monitorng preferential particles in sample; provide opaque glass support, incubate with sample, illuminate surface with light, monitor fluorescent emission, emission indicates presence of preferential particle in sample |
| 03/21/2002 | US20020034761 Methods of labelling polynucleotides with dibenzorhodamine dyes |
| 03/21/2002 | US20020034760 Treating genetic disoders; obtain nucleotide sequence sample, sequence nucleic acids, evaluate for genetic disorder, administer preferential modulator to treat genetic disorder |
| 03/21/2002 | US20020034759 Metallic solid supports modified with nucleic acids |
| 03/21/2002 | US20020034758 Novel human genes and gene expressions products: II |
| 03/21/2002 | US20020034756 Method of detection by enhancement of silver staining |
| 03/21/2002 | US20020034755 Polypeptides having a functional domain of interest and methods of identifying and using same |
| 03/21/2002 | US20020034754 Fluorescent quenching detection reagents and methods |
| 03/21/2002 | US20020034753 Novel assay for nucleic acid analysis |
| 03/21/2002 | US20020034752 Diagnosing cardiovascular disease; obtain nucleic acids, analyzing for the presence of polymorphisms, determine genotype, evaluate for cardiovascular disorders |
| 03/21/2002 | US20020034750 Determining nucleotide sequence of a target nucleic acid; generate label, insert into nucleotide sequences, separate label nucleotide sequences by size, screen for signal |
| 03/21/2002 | US20020034749 Reagents and methods useful for detecting diseases of the breast |
| 03/21/2002 | US20020034748 Genetic analysis of nucleic acid sample; detect target nucleotide sequences, generate oligonucleotide sequences, classify nucleotide sequences in sample |
| 03/21/2002 | US20020034747 Using encoded bead conjugate comprising microsphere semiconductor nanocrystal having fluorescence characteristics and polynucleotide having proximal end and distal end wherein polynucleotide is linked to microsphere at proximal end |
| 03/21/2002 | US20020034746 Computer program product for quantitative analysis of a nucleic acid amplification reaction |
| 03/21/2002 | US20020034745 Device for determining transition point in cycled propagation reaction; for use as diagnostic tools in nucleotide sequences analysis |
| 03/21/2002 | US20020034743 Nucleotide sequences coding protein for use in the detection, diagnosis, prevention and treatment of human cancers |
| 03/21/2002 | US20020034742 Disease association by stratification |
| 03/21/2002 | US20020034740 Reagents and methods useful for detecting diseases of the breast |
| 03/21/2002 | US20020034739 Peptides characteristic of certain tumors |
| 03/21/2002 | US20020034737 Methods and compositions for detection or quantification of nucleic acid species |
| 03/21/2002 | US20020034735 Applying mixed solution comprising adenovirus and undesired type of biomolecule to anion exchange chromatography resin containing binding moiety such as dimethylaminopropyl such that adenovirus binds to resin, eluting |
| 03/21/2002 | US20020034733 Novel methods for displaying (poly) pepti des/proteins on bacteriophage particles via disulfide bonds |
| 03/21/2002 | US20020034732 Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening |
| 03/21/2002 | US20020034730 For identifying compounds that bind to ion channel and may have antiarrhythmic activity |
| 03/21/2002 | US20020034729 Detecting active metabolites in sample; incubate drug with microsomal enzyme, mix glutathione, detect glutathione conjugate |
| 03/21/2002 | US20020034728 Screening compounds that modulate calcium release activated channel activity by contacting compound and calcium channel activator with calcium channel expressing cells containing reporter construct, measuring reporter gene expression |
| 03/21/2002 | US20020034513 MHC complexes and uses thereof |
| 03/21/2002 | US20020034506 Method for treatment of tumors using nucleic acid ligands to PDGF |
| 03/21/2002 | US20020033939 Instrument for selecting and depositing multicellular organisms and other large objects |
| 03/21/2002 | DE10046187A1 Verfahren zur Messung der Aktivität von Gerinnungsfaktor XIIIa A method for measuring the activity of coagulation factor XIIIa |
| 03/21/2002 | DE10044648A1 Verfahren zur Vermehrung oder zur Entfernung von Cirocoviren aus biologischem Material Method of replication or removal of Cirocoviren from biological material |
| 03/21/2002 | CA2703141A1 Oligonucleotide sequence formula for labeling oligonucleotide probes and proteins for in situ analysis |
| 03/21/2002 | CA2585083A1 Directed evolution method |
| 03/21/2002 | CA2426517A1 Methods and compositions for glycosidase assays |
| 03/21/2002 | CA2423559A1 22 human secreted proteins |
| 03/21/2002 | CA2422828A1 Novel tumor-associated marker |
| 03/21/2002 | CA2422815A1 Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of hiv/aids |
| 03/21/2002 | CA2422497A1 Transporters and ion channels |
| 03/21/2002 | CA2422489A1 Non-nucleoside reverse transcriptase inhibitor as antiretroviral therapy |
| 03/21/2002 | CA2422454A1 Compositions and methods for inducing specific cytolytic t cell responses |
| 03/21/2002 | CA2422426A1 Polymorphic bone morphogenetic protein 2 |
| 03/21/2002 | CA2422362A1 Modulation of meiotic recombination |
| 03/21/2002 | CA2422320A1 Id-1 and id-2 genes and products as diagnostic and prognostic markers and therapeutic targets for treatment of breast cancer and other types of carcinoma |
| 03/21/2002 | CA2422314A1 Microarrayed organization of transcription factor target genes |
| 03/21/2002 | CA2422310A1 Detection of microsatellite instability and its use in diagnosis of tumors |
| 03/21/2002 | CA2422278A1 Methods of diagnosis of colorectal cancer, compositions and methods of screening for colorectal cancer modulators |
| 03/21/2002 | CA2422237A1 Genes and the physics of the dna double-helix. formulation of a physics-based gene identification (pbgi) method: ab initio identification of genes in eukaryotic genomes |
| 03/21/2002 | CA2422229A1 Calcium binding proteins |
| 03/21/2002 | CA2422163A1 Isolated human kinase proteins, nucleic acid molecules and uses thereof |
| 03/21/2002 | CA2422152A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/21/2002 | CA2422091A1 Facile detection of cancer and cancer risk based on level of coordination between alleles |
| 03/21/2002 | CA2422053A1 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses tehreof |
| 03/21/2002 | CA2422032A1 The diagnosis, prevention, amelioration and/or treatment of disturbed immune function induced by disturbed lipid metabolism |